Monte Rosa Therapeutics
GLUE
#7806
Rank
NZ$0.43 B
Marketcap
$7.06
Share price
1.54%
Change (1 day)
-39.96%
Change (1 year)

Monte Rosa Therapeutics (GLUE) - Total debt

Total debt on the balance sheet as of December 2024 : NZ$76.31 Million

According to Monte Rosa Therapeutics's latest financial reports the company's total debt is NZ$76.31 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Monte Rosa Therapeutics - Total debt on balance sheet (from 2021 to 2024)

Total debt by year

Year Total debt Change
2024-12-31NZ$75.73 M4.04%
2023-12-31NZ$72.8 M-1.66%
2022-12-31NZ$74.02 M
2021-12-31N/A
2019-12-31NZ$1.11 M